retatrutide trial results news This is exciting. 👀 The TRIUMPH-4 for Lilly's investigational medication were released, showing weight loss of up to 71 lbs (~28%) over 68 weeks in the highest-dose group—far beyond VisualAbstract: Retatrutide reduces body weight

Description

It's going to take you a while to ramp up on that GLP-1 to where it's really starting to be effective for weight loss and everything else

You may experience mild side effects such as nausea or bloating, but these symptoms typically improve as your body adjusts to treatment

Dispose of the needle in your sharps container immediately ## Troubleshooting **Powder will not dissolve:** Ensure the water ran down the vial wall

This represents a significant consideration for healthcare providers and patients making treatment decisions

The NIHR Innovation Observatory states that it has no Marketing Authorisation in the EU/UK and remains in phase III development , which means it should be understood as an investigational medicine rather than a treatment clinicians can routinely deploy in standard practice (NIHR Innovation Observatory briefing on retatrutide)